Ipratropium bromide and Excedrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ipratropium bromide (ipratropium bromide) and Excedrin (acetaminophen; aspirin; caffeine). Common drug interactions include upper respiratory tract infection among females and ear infection among males.

The phase IV clinical study analyzes what interactions people have when they take Ipratropium bromide and Excedrin. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Excedrin?

Excedrin has active ingredients of acetaminophen; aspirin; caffeine. It is often used in headache. eHealthMe is studying from 22,740 Excedrin users. Check the latest studies of Excedrin.



On Aug, 02, 2026

21 people who take Ipratropium bromide and Excedrin together, and have interactions are studied.

Ipratropium bromide and Excedrin drug interactions.

What are the common drug interactions of Ipratropium Bromide and Excedrin, by gender? *:

female:

  1. Upper respiratory tract infection
  2. Pneumonia
  3. Dyspnoea (difficult or laboured respiration)
  4. Rash
  5. Fatigue (feeling of tiredness)
  6. Rash erythematous (redness of the skin)
  7. Loss of consciousness
  8. Dry skin
  9. Influenza like illness
  10. Injection site haemorrhage (bleeding from injection site)

male:

  1. Ear infection
  2. Immunodeficiency
  3. Hypertension (high blood pressure)
  4. Influenza
  5. Infusion related reaction
  6. Infusion site erythema (reddening of the skin at infusion site)
  7. Infusion site rash
  8. Infusion site urticaria (rash of round, red welts on the skin at infusion site)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Ipratropium Bromide and Excedrin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal discomfort
  2. Asthenia (weakness)
  3. Cough
  4. Diarrhoea
  5. Dizziness
  6. Hyperhidrosis (abnormally increased sweating)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Rhinorrhoea (watery mucus discharge from the nose)
  10. Sinus congestion (blockage of sinus)

40-49:

  1. Abdominal distension
  2. Dyspnoea (difficult or laboured respiration)
  3. Fall
  4. Head injury
  5. Ligament sprain (ligament stretched)
  6. Local swelling (swelling at the site of some application of substance or injury)
  7. Loss of consciousness
  8. Neck injury
  9. Neck pain
  10. Rib fracture

50-59:

  1. Adverse drug reaction
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  4. Blood glucose decreased
  5. Cough
  6. Fatigue (feeling of tiredness)
  7. Hypertension (high blood pressure)
  8. Influenza
  9. Infusion related reaction
  10. Infusion site erythema (reddening of the skin at infusion site)

60+:

  1. Ear infection
  2. Immunodeficiency
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Platelet count decreased
  5. Rash pruritic (redness with itching)
  6. Thrombosis (formation of a blood clot inside a blood vessel)
  7. Back pain
  8. Drug administration error
  9. Ear discomfort
  10. Herpes zoster

What are the existing conditions these people have? *

  1. Pain: 5 people, 23.81%
  2. Migraine (headache): 5 people, 23.81%
  3. Immunodeficiency Common Variable: 5 people, 23.81%
  4. Asthma: 5 people, 23.81%
  5. Depression: 4 people, 19.05%
  6. Multiple Myeloma (cancer of the plasma cells): 3 people, 14.29%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 14.29%
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 14.29%
  9. Rash Pruritic (redness with itching): 2 people, 9.52%
  10. Osteoporosis (bones weak and more likely to break): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and Excedrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ipratropium bromide and Excedrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Excedrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ipratropium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Excedrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and acetaminophen; aspirin; caffeine (the active ingredients of Ipratropium bromide and Excedrin, respectively), and Ipratropium bromide and Excedrin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: